Trading in OSRH and OSRHW is set to be suspended on August 26, 2026. The hearing request only delays formal delisting, not the suspension. Traders should expect a complete loss of liquidity in the near term and should exit positions immediately if possible. Monitor for the Panel's decision, but the outlook is highly negative.
Price Chart
Executive Summary
OSR Health received a delisting determination from Nasdaq for non-compliance with the minimum bid price rule and has appealed by requesting a hearing before a Nasdaq Hearings Panel. Trading in OSRH and OSRHW is scheduled to be suspended on August 26, 2026, and the hearing request will not stay that suspension, though it may delay the formal delisting. The company's ability to remain listed is highly uncertain, creating significant downside risk for shareholders.
Key Facts
- Nasdaq determined to delist OSR Health's common stock and warrants for non-compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)).
- Trading suspension is scheduled for the opening of business on August 26, 2026, and the hearing request will not stay this suspension.
- The company submitted a hearing request on August 25, 2026, which is expected to stay the filing of Form 25-NSE and the formal delisting pending the Panel's decision.
- There is no assurance the Panel will grant continued listing or that the company will regain compliance.
Financial Impact
Delisting from Nasdaq would severely impair liquidity and likely lead to a significant decline in the stock price, potentially to near-zero value for a $10M market cap company. No specific financial figures are provided in the filing.
Risk Factors
- Immediate trading suspension on August 26, 2026, with no stay available.
- High probability of permanent delisting from Nasdaq, leading to OTC trading and severe price deterioration.
- No guarantee the Panel will accept any compliance plan or that the company can regain compliance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-093379 |
| Document: 0001213900-26-093379-index.html | 0001213900-26-093379 |
| Document: 0001213900-26-093379.txt | 0001213900-26-093379 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K | $0.1165 | awaiting T+20 | — | $0.1925 (−65.24%) |
Oct 2, 2026 24d ago | 8-K | $0.2410 | awaiting T+20 | — | $0.1925 (−20.12%) |
Aug 28, 2026 8w ago | 8-K | $0.1165 $0.1165 | · 0.00% | ▲ +0.26% | $0.1925 (−65.24%) |
Aug 25, 2026 9w ago | 8-K | $0.1165 $0.1165 | · 0.00% | ▲ +0.98% | $0.1925 (−65.24%) |
Aug 19, 2026 9w ago | 8-K | $0.2949 $0.1165 | ▲ +60.50% | ▲ +60.50% | $0.1925 (+34.72%) |
Jul 31, 2026 12w ago | 8-K | $0.4480 $0.1165 | ▼ −74.00% | ▼ −76.98% | $0.1925 (−57.03%) |
Jun 11, 2026 19w ago | DEFA14A | $0.4192 $0.3290 | ▼ −21.52% | ▼ −23.41% | $0.1925 (−54.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers